Inhibition of IκB kinase β restrains oncogenic proliferation of pancreatic cancer cells

Journal of Medical and Dental Sciences

Volumn 55, Issue 1, 2008, Pages 49-59

  Ochiai, Takanori ^a   Saito, Yasunori ^a   Saitoh, Tatsuya ^b   Dewan, Md Zahidunnabi ^a   Shioya, Ayumi ^a   Kobayashi, Maki ^a   Kawachi, Hiroshi ^a   Muto, Susumu ^c   Itai, Akiko ^c   Uota, Shin ^a   Eishi, Yoshinobu ^a   Yamamoto, Naoki ^a   Tanaka, Shinji ^a   Arii, Shigeki ^a   Yamaoka, Shoji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Inst of Medicinal Molecular Design   (Japan)

Author keywords

I B kinase (IKK ); IMD 0354; Nuclear factor B (NF B); Pancreatic cancer; RNA interference

Indexed keywords

BENZAMIDE DERIVATIVE; ENZYME INHIBITOR; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N (3,5 BIS(TRIFLUOROMETHYL)PHENYL) 5 CHLORO 2 HYDROXYBENZAMIDE; N-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-5-CHLORO-2-HYDROXYBENZAMIDE;

ANIMAL; ARTICLE; BINDING COMPETITION; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PANCREAS TUMOR; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BENZAMIDES; BINDING, COMPETITIVE; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE KNOCKDOWN TECHNIQUES; HUMANS; I-KAPPA B KINASE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; NF-KAPPA B; PANCREATIC NEOPLASMS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 52449128774     PISSN: 13428810     EISSN: 13428810     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Wray CJ, Ahmad SA, Matthews JB,et al. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology. 2005;128:1626-41.
2. Li D, Xie K, Wolff R,et al. Pancreatic cancer. Lancet. 2004; 363:1049-57.
3. Bergenfeldt M, Albertsson M. Current state of adjuvant therapy in resected pancreatic adenocarcinoma. Acta Oncol. 2006;45:124-35.
4. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46:705-16.
5. Perkins ND. The Rel/NF-kappa B family: friend and foe. Trends Biochem Sci. 2000;25:434-40.
6. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225-60.
7. Verma IM, Stevenson JK, Schwarz EM,et al. Rel/NF-kappa B/l kappa B family: intimate tales of association and dissociation. Genes Dev. 1995;9:2723-35.
8. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109 Suppl:S81-96.
9. DiDonato JA, Hayakawa M, Rothwarf DM,et al. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 1997;388:548-554.
10. Mercurio F, Zhu H, Murray BW,et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science. 1997;278:860-66.
11. Li Y, Kang J, Friedman J, et al. Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc Natl Acad Sci U S A. 1999;96:1042-47.
12. Ducut Sigala JL, Bottero V, Young DB,et al. Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science. 2004;304:1963-67.
13. Stancovski I, Baltimore D. NF-kappaB activation: the I kappaB kinase revealed? Cell. 1997;91:299-302.
14. O'Connell MA, Bennett BL, Mercurio F,et al. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem. 1998;273:30410-14.
15. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431-36.
16. Tomita M, Kawakami H, Uchihara JN,et al. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type l-infected T-cell lines and primary adult T-cell leukemia cells. Int J Cancer. 2006;118:765-72.
17. Izban KF, Ergin M, Huang Q,et al. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells. Mod Pathol. 2001;14:297-310.
18. Sanda T, lida S, Ogura H,et al. Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor. Clin Cancer Res. 2005;11:1974-82.
19. Tanaka A, Muto S, Konno M,et al. A new I kappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition. Cancer Res. 2006;66:419-26.
20. Yemelyanov A, Gasparian A, Lindholm P,et al. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. Oncogene. 2006;25:387-98.
21. Li L, Aggarwal BB, Shishodia S,et al. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer. 2004;101:2351-62.
22. Yamaoka S, Courtois G, Bessia C, et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998;93:1231-40.
23. Munoz E, Courtois G, Veschambre P,et al. Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3. J Virol. 1994;68:8035-44.
24. Yamaoka S, Inoue H, Sakurai M,et al. Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. Embo J. 1996;15:873-87.
25. Ali SH, O'Donnell AL, Balu D,et al. Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res. 2000;60:7094-98.
26. Tanaka A, Konno M, Muto S,et al. A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors. Blood. 2005;105:2324-31.
27. Brand RE, Tempera MA. Pancreatic cancer. Curr Opin Oncol. 1998;10:362-66.
28. Jaffee EM, Hruban RH, Canto M,et al. Focus on pancreas cancer. Cancer Cell. 2002;2:25-28.
29. Arlt A, Vorndamm J, Muerkoster S,et al. Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res. 2002;62:910-16.
30. Muerkoster S, Wegehenkel K, Arlt A,et al. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res. 2004;64:1331-37.
31. Banerjee D, Mayer-Kuckuk P, Capiaux G,et al. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta. 2002;1587:164-73.
32. Kang HC, Kim IJ, Park JH,et al. Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res. 2004;10:272-84.
33. Wang W, Abbruzzese JL, Evans DB,et al. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res. 1999;5:119-27.
34. Schmid RM, Adler G. NF-kappaB/rel/lkappaB: implications in gastrointestinal diseases. Gastroenterology. 2000;118:1208-28.
35. Liptay S, Weber CK, Ludwig L,et al. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer. Int J Cancer. 2003;105:735-46.
36. Arlt A, Vorndamm J, Breitenbroich M,et al. Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene. 2001;20:859-68.
37. Muerkoster S, Arlt A, Witt M,et al. Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. Int J Cancer. 2003;104:469-76.